Clinical significance of and outcomes for Bacteroides fragilis bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 3, 2009, Pages 243-250

  Cheng, Chun Wen ^a   Lin, Huang Shen ^a   Ye Jr , Jung ^a   Yang, Chien Chang ^a   Chiang, Ping Cherng ^a   Wu, Ting Shu ^a   Lee, Ming Hsun ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Bacteremia; Bacteria, anaerobic; Bacteroides fragilis

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL INFECTION; ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTEREMIA; BACTEROIDES FRAGILIS; BACTEROIDES INFECTION; COMORBIDITY; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR; SEPTIC SHOCK; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BACTEREMIA; BACTEROIDES FRAGILIS; BACTEROIDES INFECTIONS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 70349932523     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Goldstein EJ. Anaerobic bacteremia. Clin Infect Dis. 1996;23(Suppl 1):97-101.
2. Lombardi DP, Engleberg NC. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med. 1992;92:53-60.
3. Arzese A, Trevisan R, Menozzi MG, Botta GA, on behalf of the Italian Anaerobe Study Group. Anaerobe-induced bacteremia in Italy: a nationwide survey. Clin Infect Dis. 1995;20(Suppl 2):230-232
4. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis. 1991;13:633-636
5. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis. 2007;44:895-900.
6. Salonen JH, Eerola E, Meurman O. Clinical significance and outcome of anaerobic bacteremia. Clin Infect Dis. 1998;26:1413-1417 (Pubitemid 28270174)
7. Blairon L, Gheldre YD, Delaere B, Sonet A, Bosly A, Glupczynski Y. A 62-month retrospective epidemiological survey of anaerobic bacteremia in a university hospital. Clin Microbiol Infect. 2006;12:527-532 (Pubitemid 43740763)
8. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteremia in cancer patient: a 6-year retrospective study. Clin Microbiol Infect. 2005;11:724-729 (Pubitemid 41167338)
9. Hung MN, Chen SY, Wang JL, Chang SC, Hsueh PR, Liao CH, et al. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center. J Microbiol Immunol Infect. 2005;38:436-443
10. Redondo MC, Arbo MD, Grindlinger J, Snydman R. Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis. 1995;20:1492-1496
11. Nguyen MH, Yu VL, Morris AJ, McDermott L, Wagener MW, Harrell L, et al. Antimicrobial resistance and clinical outcome of Bacteroides bacteremia: findings of a multicenter prospective observational trial. Clin Infect Dis. 2000;30:870-876 (Pubitemid 32250323)
12. Lee CS, Hwang B, Chung RL, Tang RB. The assessment of anaerobic blood cultures in children. J Microbiol Immunol Infect. 2000;33:49-52. (Pubitemid 30196473)
13. Tsao YT, Lin SH, Cheng CJ, Chang FY. Pylephlebitis associated with acute infected choledocholithiasis. Am J Med Sci. 2006;332:85-87
14. Wilson JR, Limaye AP. Risk factors for mortality in patients with anaerobic bacteremia. Eur J Clin Microbiol Infect Dis. 2004;23:310-316 (Pubitemid 38669941)
15. Vazquez F, Mendez FJ, Perez F, Mendoza MC. Anaerobic bacteremia in a general hospital: retrospective five-year analysis. Rev Infect Dis. 1987;9:1038-1043
16. Murray PR, Baron EJ, Pfaller MH, Tenover FC, Yolken RH. Manual of clinical microbiology. 8th ed. Herndon: ASM Press; 2003; 835-900.
17. National Committee for Clinical Laboratory Standards. Methods for antimicrobial susceptibility testing of anaerobic bacteria. Approved standard. 5th ed. NCCLS document M11-A5. Wayne: National Committee for Clinical Laboratory Standards; 2001.
18. Wexler HM. Bacteroides: the good, th bad, the nitty-gritty. Clin Microbiol Rev. 2007;20:593-621.
19. Lipsky BA, Berendt AR, Deery HG, Embil JM, Joseph WS, Karchmer AW, et al. Diagnosis and treatment of diabetes foot infection. Clin Infect Dis. 2004;39:885-910. (Pubitemid 39328144)
20. Repine JE, Clawson CC, Goetz FC. Bactericidal function of neutrophils from patients with acute bacterial infection and from diabetes. J Infect Dis. 1980;142:869-875
21. Fainstein V, Elting LS, Bodey GP. Bacteremia caused by non-sporulating anaerobes in cancer patients: a 12-year experience. Medicine. 1989;68:151-162 (Pubitemid 19132412)
22. Simon GL, Gelfand JA, Connolly RA, O'Donnell TF, Gorbach SL. Experimental Bacteroides fragilis bacteremia in a primate model: evidence that Bacteroides fragilis does not promote the septic shock syndrome. J Trauma. 1985;25:1156-1162
23. Chen YM, Lee HC, Chang CM, Chuang YC, Ko WC. Clostridium bacteremia: emphasis on the poor prognosis in cirrhotic patients. J Microbiol Immunol Infect. 2001;34:113-118